The purpose of this project is to gather preliminary data on cholinergic control of insulin release in our population of women with a history of gestational diabetes (GDM) [and the attendant predisposition to develop NIDDM]. We have previously shown that the first phase insulin release in these women is not enhanced by alpha adrenergic blockade (using Dibenzyline). Older literature, however, has documented a significant enhancement of first phase release using phentolamine for alpha adrenergic blockade. We suggest that phentolamine has cholinergic effects [as well as alpha adrenergic antagonism] and that these effects may be the over-riding influence in those studies. We plan to replicate the reported effect of phentolamine (enhanced early insulin response to IV glucose) in these women, and then demonstrate that this effect is, contrary to previous thought, cholinergic in nature. The primary outcome variable is first phase insulin release. METHODS: We will use a with-in subjects, repeated measures design, studying 6-8 women with a history of gestational diabetes. Each will undergo a one-hour IVGTT on each of 3 consecutive days--baseline control, phentolamine IVGTT, phentolamine/atropine IVGTT. Studies will be conducted in the first 14 days of the menstrual cycle to control for hormonal effects on glucose regulation and subjects will be those previously completing the alpha adrenergic blockade study. IVGTT with drug combination will be conducted in the Clinical Electrophysiology Lab at Duke Hospital North, in collaboration with J. Marcus Wharton, M.D. During each IVGTT, women will receive an IV infusion. For baseline testing, this will consist of normal saline. For the phentolamine IVGTT, subjects will receive phentolamine, 5.0 mg bolus IV followed by 0.5 mg/minute. For the combined drug IVGTT, subjects will receive the identical phentolamine dosing, but with the addition of atropine, .035mg/kg body weight IV bolus given 10 minutes prior to glucose injection. PLANS: This project has been on hold since spring of 1996 due to the unavailability of phentolamine. The manufacturer has estimated that it will again become available early this year (1997). We intend to complete at least one more gestational [history] subject and 4-5 parous controls. With the first data (on 5 gestationals), it has become clear that data on normals is essential to interpret these preliminary findings. This project data set will presumably be used to develop a proposal to more fully study cholinergic influence on glucose regulation. SIGNIFICANCE: Any proven difference in the autonomic regulation of glucose metabolism in high risk individuals is potentially significant in that it may lead to interventions to cancel or delay the onset of NIDDM.

Project Start
1975-10-01
Project End
1998-11-30
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
36
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Duke University
Department
Type
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Askie, Lisa M; Darlow, Brian A; Finer, Neil et al. (2018) Association Between Oxygen Saturation Targeting and Death or Disability in Extremely Preterm Infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration. JAMA 319:2190-2201
Srinivasan, Lakshmi; Page, Grier; Kirpalani, Haresh et al. (2017) Genome-wide association study of sepsis in extremely premature infants. Arch Dis Child Fetal Neonatal Ed 102:F439-F445
Denson, Lee A; McDonald, Scott A; Das, Abhik et al. (2017) Early Elevation in Interleukin-6 is Associated with Reduced Growth in Extremely Low Birth Weight Infants. Am J Perinatol 34:240-247
James, Jennifer; Munson, David; DeMauro, Sara B et al. (2017) Outcomes of Preterm Infants following Discussions about Withdrawal or Withholding of Life Support. J Pediatr 190:118-123.e4
Younge, Noelle; Goldstein, Ricki F; Bann, Carla M et al. (2017) Survival and Neurodevelopmental Outcomes among Periviable Infants. N Engl J Med 376:617-628
Archer, Stephanie Wilson; Carlo, Waldemar A; Truog, William E et al. (2016) Improving publication rates in a collaborative clinical trials research network. Semin Perinatol 40:410-417
Ahmed, Zuhayer; Prasad, Indrajit; Rahman, Hafizur et al. (2016) A Male with Extreme Subcutaneous Insulin Resistance: A Case Report. Rom J Diabetes Nutr Metab Dis 23:209-213
Phelps, Dale L; Ward, Robert M; Williams, Rick L et al. (2016) Safety and pharmacokinetics of multiple dose myo-inositol in preterm infants. Pediatr Res 80:209-17
Barroso, Julie; Leserman, Jane; Harmon, James L et al. (2015) Fatigue in HIV-Infected People: A Three-Year Observational Study. J Pain Symptom Manage 50:69-79
Stafford-Smith, Mark; Li, Yi-Ju; Mathew, Joseph P et al. (2015) Genome-wide association study of acute kidney injury after coronary bypass graft surgery identifies susceptibility loci. Kidney Int 88:823-32

Showing the most recent 10 out of 128 publications